Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06911996 · ClinicalTrials.gov registry record · NA

The WOW Project (WOW): Wonders Of The World Through Virtual Reality for Hospitalized Children

A NA study of Virtual Reality, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06911996: Recruiting NA study of Virtual Reality, sponsored by Stanford University.

NCT06911996 is a NA study of Virtual Reality that is actively recruiting participants, run by Stanford University. The registered enrollment target is 100 participants, above the 87-participant average among 19 other Virtual Reality trials with a reported enrollment target (15% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06911996, a NA study of Virtual Reality, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Hospitalized pediatric patients are unable to leave the hospital to engage in traditional learning environments. Patients often feel depressed, disconnected from learning, and socially withdrawn. The Stanford Chariot Program proposes a partnership with the Palo Alto Unified Hospital School at Stanford Children's Health to reignite patients' emotional well-being through learning. The WOW Project aims to use virtual reality (VR) to travel with hospitalized children to the Wonders of the World (WOW). Combining this immersive learning modality with complementary hands-on activities at the bedside, the investigators will transport them from their hospital room into a nurturing virtual environment to stimulate their emotional, mental, and social growth while they are physically healing. The investigators will evaluate their overall joy and awe of learning by using standardized emotional scales.

Primary Outcome

The primary outcome will be AWE measured by the AWE-SF Survey - The Awe Experience Short Form Scale. The survey contains 12 items about awe experience. Each item was rated on a 7-point scale (1 = Strongly Disagree, 7 = Strongly Agree).

Conditions Studied

Interventions

  • BEHAVIORAL Virtual Reality

Study Locations (1)

California

  • Lucile Packard Children's Hospital Stanford - Palo Alto

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-07-10
Est. Completion 2026-08-31
Phase NA
Stanford University

1,744 total trials

What NCT06911996 shows while recruiting

NCT06911996 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 87-participant average among 19 other Virtual Reality trials with a reported enrollment target (15% higher).

The record links to 1 condition, with Virtual Reality appearing as the primary indexed condition, and to 1 intervention - of which Virtual Reality is the first listed.

NCT06911996 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06911996 about?

NCT06911996 is a clinical study titled "The WOW Project (WOW): Wonders Of The World Through Virtual Reality for Hospitalized Children". Hospitalized pediatric patients are unable to leave the hospital to engage in traditional learning environments. Patients often feel depressed, disconnected from learning, and socially withdrawn. The Stanford Chariot Program proposes a partnership with the Palo Alto Unified Hospital School at Stanfo...

What is the current status of trial NCT06911996?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-07-10. Estimated completion is 2026-08-31.

What conditions does trial NCT06911996 study?

This clinical trial studies the following conditions: Virtual Reality.

What interventions are being tested in trial NCT06911996?

The interventions under investigation include: Virtual Reality (BEHAVIORAL).

Who is sponsoring clinical trial NCT06911996?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06911996 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Virtual Reality

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06911996's enrollment target sits among peer trials

100 6th of 19 higher than 14 of 19 other Virtual Reality trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Virtual Reality trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06911996, the US trial registry maintained by the National Library of Medicine. NCT06911996 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.